Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

melanoma

  • Dynamic Tumor-Specific MHC-II Immuno-PET Predicts the Efficacy of Checkpoint Inhibitor Immunotherapy in Melanoma
    You have access
    Dynamic Tumor-Specific MHC-II Immuno-PET Predicts the Efficacy of Checkpoint Inhibitor Immunotherapy in Melanoma
    Zhen Yang, Feng Li, Yuqian Huang, Na Yin, Junjun Chu, Ying Ma, Roderic I. Pettigrew, Dale J. Hamilton, Diego R. Martin and Zheng Li
    Journal of Nuclear Medicine November 1, 2022, 63 (11) 1708-1714; DOI: https://doi.org/10.2967/jnumed.121.263151
  • Technologic (R)Evolution Leads to Detection of More Sentinel Nodes in Patients with Melanoma in the Head and Neck Region
    You have access
    Technologic (R)Evolution Leads to Detection of More Sentinel Nodes in Patients with Melanoma in the Head and Neck Region
    Danique M.S. Berger, Nynke S. van den Berg, Vincent van der Noort, Bernies van der Hiel, Renato A. Valdés Olmos, Tessa A. Buckle, Gijs H. KleinJan, Oscar R. Brouwer, Lenka Vermeeren, Baris Karakullukçu, Michiel W.M. van den Brekel, Bart A. van de Wiel, Omgo E. Nieweg, Alfons J.M. Balm, Fijs W.B. van Leeuwen and W. Martin C. Klop
    Journal of Nuclear Medicine October 1, 2021, 62 (10) 1357-1362; DOI: https://doi.org/10.2967/jnumed.120.246819
  • Prognostic Value of Bone Marrow Metabolism on Pretreatment <sup>18</sup>F-FDG PET/CT in Patients with Metastatic Melanoma Treated with Anti-PD-1 Therapy
    You have access
    Prognostic Value of Bone Marrow Metabolism on Pretreatment 18F-FDG PET/CT in Patients with Metastatic Melanoma Treated with Anti-PD-1 Therapy
    Ryusuke Nakamoto, Lisa C. Zaba, Tie Liang, Sunil Arani Reddy, Guido Davidzon, Carina Mari Aparici, Judy Nguyen, Farshad Moradi, Andrei Iagaru and Benjamin Lewis Franc
    Journal of Nuclear Medicine October 1, 2021, 62 (10) 1380-1383; DOI: https://doi.org/10.2967/jnumed.120.254482
  • Synthesis of the PET Tracer <sup>124</sup>I-Trametinib for MAPK/ERK Kinase Distribution and Resistance Monitoring
    You have access
    Synthesis of the PET Tracer 124I-Trametinib for MAPK/ERK Kinase Distribution and Resistance Monitoring
    Edwin C. Pratt, Elizabeth Isaac, Evan P. Stater, Guangbin Yang, Ouathek Ouerfelli, Nagavarakishore Pillarsetty and Jan Grimm
    Journal of Nuclear Medicine December 1, 2020, 61 (12) 1845-1850; DOI: https://doi.org/10.2967/jnumed.120.241901
  • You have access
    First-in-Humans Imaging with 89Zr-Df-IAB22M2C Anti-CD8 Minibody in Patients with Solid Malignancies: Preliminary Pharmacokinetics, Biodistribution, and Lesion Targeting
    Neeta Pandit-Taskar, Michael A. Postow, Matthew D. Hellmann, James J. Harding, Christopher A. Barker, Joseph A. O’Donoghue, Martha Ziolkowska, Shutian Ruan, Serge K. Lyashchenko, Frank Tsai, Michael Farwell, Tara C. Mitchell, Ron Korn, William Le, Jason S. Lewis, Wolfgang A. Weber, Deepak Behera, Ian Wilson, Michael Gordon, Anna M. Wu and Jedd D. Wolchok
    Journal of Nuclear Medicine April 1, 2020, 61 (4) 512-519; DOI: https://doi.org/10.2967/jnumed.119.229781
  • You have access
    131I-IITM and 211At-AITM: Two Novel Small-Molecule Radiopharmaceuticals Targeting Oncoprotein Metabotropic Glutamate Receptor 1
    Lin Xie, Masayuki Hanyu, Masayuki Fujinaga, Yiding Zhang, Kuan Hu, Katsuyuki Minegishi, Cuiping Jiang, Fuki Kurosawa, Yukie Morokoshi, Huizi Keiko Li, Sumitaka Hasegawa, Kotaro Nagatsu and Ming-Rong Zhang
    Journal of Nuclear Medicine February 1, 2020, 61 (2) 242-248; DOI: https://doi.org/10.2967/jnumed.119.230946
  • You have access
    Metabolic Biomarker–Based BRAFV600 Mutation Association and Prediction in Melanoma
    Hanna Saadani, Bernies van der Hiel, Else A. Aalbersberg, Ioannis Zavrakidis, John B.A.G. Haanen, Otto S. Hoekstra, Ronald Boellaard and Marcel P.M. Stokkel
    Journal of Nuclear Medicine November 1, 2019, 60 (11) 1545-1552; DOI: https://doi.org/10.2967/jnumed.119.228312
  • You have access
    68Ga-DOTA-E[c(RGDfK)]2 PET Imaging of SHARPIN-Regulated Integrin Activity in Mice
    Riikka Siitonen, Emilia Peuhu, Anu Autio, Heidi Liljenbäck, Elina Mattila, Olli Metsälä, Meeri Käkelä, Tiina Saanijoki, Ingrid Dijkgraaf, Sirpa Jalkanen, Johanna Ivaska and Anne Roivainen
    Journal of Nuclear Medicine October 1, 2019, 60 (10) 1380-1387; DOI: https://doi.org/10.2967/jnumed.118.222026
  • You have access
    18F-FDG PET/CT for Monitoring of Ipilimumab Therapy in Patients with Metastatic Melanoma
    Kimiteru Ito, Rebecca Teng, Heiko Schöder, John L. Humm, Ai Ni, Laure Michaud, Reiko Nakajima, Rikiya Yamashita, Jedd D. Wolchok and Wolfgang A. Weber
    Journal of Nuclear Medicine March 1, 2019, 60 (3) 335-341; DOI: https://doi.org/10.2967/jnumed.118.213652
  • You have access
    Biodistribution, Radiation Dosimetry, and Clinical Application of a Melanin-Targeted PET Probe, 18F-P3BZA, in Patients
    Xiaowei Ma, Shengjun Wang, Shuailiang Wang, Daliang Liu, Xiaohu Zhao, Hao Chen, Fei Kang, Weidong Yang, Jing Wang and Zhen Cheng
    Journal of Nuclear Medicine January 1, 2019, 60 (1) 16-22; DOI: https://doi.org/10.2967/jnumed.118.209643

Pages

  • Next
  • 1
  • 2
  • 3
SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire